Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Foundation Medicine Inc (NASDAQ:FMI)

41.05
Delayed Data
As of 10:18am ET
 +0.15 / +0.37%
Today’s Change
17.10
Today|||52-Week Range
43.15
+131.92%
Year-to-Date
ETF Winner of 1H17 and its Top 5 Stocks
10:06am / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close40.90
Today’s open41.10
Day’s range40.50 - 41.70
Volume22,786
Average volume (3 months)277,731
Market cap$1.5B
Dividend yield--
Data as of 10:18am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-19.05%
Earnings growth (this year)-33.64%
Earnings growth (next 5 years)--
Revenue growth (last year)+25.39%
P/E ratioNM
Price/Sales5.27
Price/Book8.75

Competitors

 Today’s
change
Today’s
% change
GHDXGenomic Health Inc+0.22+0.69%
KANGiKang Healthcare Gro...+0.12+0.96%
NEONeogenomics Inc-0.04-0.46%
NTRANatera Inc+0.20+1.81%
Data as of 10:34am ET, 06/28/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$1.11
Annual revenue (last year)$116.9M
Annual profit (last year)-$113.2M
Net profit margin-96.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Troy Cox
President &
Chief Operating Officer
Steven J. Kafka
Corporate headquarters
Cambridge, Massachusetts

Forecasts